PolyMedix Hid Drug's Flaws Before $20M Stock Deal, Suit Says
PolyMedix Inc. was slapped with a lawsuit in Pennsylvania federal court Monday by a putative class of investors who say the experimental drug company misled the public about a flawed anti-stroke...To view the full article, register now.
Already a subscriber? Click here to view full article